CAS NO: | 252260-02-9 |
包装 | 价格(元) |
100mg | 电议 |
250mg | 电议 |
500mg | 电议 |
生物活性 | Posizolid (AZD2563), anoxazolidinoneantibiotic, is developed byAstraZenecafor the study ofbacterialinfections. Posizolid shows very goodanti-mycobacterialactivity[1]. | ||||||||||||||||
IC50& Target |
| ||||||||||||||||
体外研究 (In Vitro) | Posizolid is determined the activity of against 250 highly resistant pneumococci and 267 drug-susceptible isolates. Posizolid MICs for 50 and 90% of the strains tested are 1 and 2 μg/ml and 0.5 and 1 μg/ml, respectively, for the two isolate groups[2]. | ||||||||||||||||
体内研究 (In Vivo) | AZD5847 DSP (AZD2563 is prodrug) could not be detected in plasma 5 min after oral administration, suggesting rapid conversion of the prodrug to the parent molecule.
| ||||||||||||||||
分子量 | 465.40 | ||||||||||||||||
Formula | C21H21F2N3O7 | ||||||||||||||||
CAS 号 | 252260-02-9 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |